Skip to content

Serotonin: all studies

Page 264 of 407: studies 2,631 to 2,640 of 4,066, newest first. Back to the serotonin overview

Research

The effects of ketamine and methamphetamine on neurotransmitters, glutamate receptors, and conditioned place preference in rat.

Legal medicine (Tokyo, Japan) November 2023 Yanxia Peng, Yihang Wang, Linlin Liu et al.

Combined methamphetamine (MA) and ketamine (KET) abuse is a serious issue. At present, however, few studies have explored the mechanism underlying their combined addiction. We established a rat conditioned place preference (CPP) model. We investigated the role of dopamine (DA), 5-hydroxytryptamine (5-HT), monoamine oxidase (MAO), glutamate receptor 1 (GluR1), and glutamate receptor 2 (GluR2) in...

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias.

European Neuropsychopharmacology November 1, 2023 Michael James Winkelman, Attila Szabo, Ede Frecska 26 citations

Alzheimer's Disease (AD) is a currently incurable but increasingly prevalent fatal and progressive neurodegenerative disease, demanding consideration of therapeutically relevant natural products and their synthetic analogues. This paper reviews evidence for effectiveness of natural and synthetic psychedelics in the treatment of AD causes and symptoms. The plastogenic effects of serotonergic...

Addiction specialists' attitudes toward psychedelics: A National Survey.

American Journal on Addictions November 1, 2023 Amanda Kim, Joji Suzuki 15 citations

In recent years, there has been accelerating scientific and public interest in the use of psychedelics to treat mental health disorders. Our study's objective was to assess the attitudes of addiction specialists regarding therapeutic psychedelics. Our study utilized an anonymous online survey to assess the opinions of 145 addiction specialists regarding the therapeutic promise, potential risks,...

UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice.

Neuropsychopharmacology November 1, 2023 Daniel Ryskamp Rijsketic, Austen B Casey, Daniel A. N. Barbosa et al. 49 citations

The effects of context on the subjective experience of serotonergic psychedelics have not been fully examined in human neuroimaging studies, partly due to limitations of the imaging environment. Here, we administered saline or psilocybin to mice in their home cage or an enriched environment, immunofluorescently-labeled brain-wide c-Fos, and imaged iDISCO+ cleared tissue with light sheet...

Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential.

Cureus November 1, 2023 Priyanshu Raj, Shyambabu Rauniyar, Bhagyesh Sapkale 8 citations

Serotonergic hallucinogens also referred to as psychedelics, are psychoactive substances that profoundly alter perception, mood, and cognitive processes. These substances, historically intertwined with religious and cultural rituals, offer profound effects that extend beyond mere hallucinations to profoundly altered states of consciousness. Notable compounds like Lysergic acid diethylamide...

DOI: 10.7759/cureus.48719 (opens in new tab) Full text (opens in new tab) Hallucinogens uses Psychedelic drug research Psychedelic drugs Psychedelic medicines +4

‘’The Science Behind Raj Yoga Meditation-A Narrative Review’’

Advancement in Yoga and Physical Therapy October 31, 2023 2 citations

On invitation to write an article on Yoga here we decided to write on science of Raj yoga meditation (RM). Normally besides the classic asana-based meditations there are 3 kinds of meditations i) Contemplation/ Concentration based ii) Mindful based iii) Love kind of meditation. Despite so much scepticism the western world found results with meditation and according to them Mindful based...

Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study

Frontiers in Psychiatry October 31, 2023 Albino J Oliveira-Maia, Benoit Rive, Joachim Morrens et al. 6 citations

BackgroundThe efficacy of esketamine nasal spray (NS) as a rapid-acting agent for treatment resistant depression (TRD) was demonstrated in comparisons with placebo, when both were given in addition to a newly initiated selective serotonin reuptake inhibitor (SSRI)/serotonin norepinephrine reuptake inhibitor (SNRI). How esketamine NS compares with commonly used real-world (RW) polypharmacy...

DOI: 10.3389/fpsyt.2023.1250987 (opens in new tab) Full text (opens in new tab) Esketamine nasal spray Treatment resistant depression Real-world evidence Indirect comparison +2

Psychedelics action and schizophrenia.

Pharmacological Reports October 30, 2023 Marzena Maćkowiak 20 citations

Abstract Psychedelics are compounds acting by serotonin 5-hydroxytryptamine (5-HT) 2A receptor activation and induce several behavioral responses. They are of special interest because of their positive effects on neuropsychiatric disorders (depression and posttraumatic stress disorder). However, several findings revealed that some psychedelic actions are similar to symptoms observed in...

DOI: 10.1007/s43440-023-00546-5 (opens in new tab) Full text (opens in new tab) Psychedelics Schizophrenia Consciousness Mental health

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics

Biology October 28, 2023 Blerida Banushi, Vince Polito 26 citations

Psychedelic substances have gained significant attention in recent years for their potential therapeutic effects on various psychiatric disorders. This review delves into the intricate cellular neurobiology of psychedelics, emphasizing their potential therapeutic applications in addressing the global burden of mental illness. It focuses on contemporary research into the pharmacological and...

Cardiovascular safety of psychedelic medicine: current status and future directions

Pharmacological Reports October 24, 2023 Agnieszka Wsół 56 citations

Abstract Psychedelics are powerful psychoactive substances that alter perception and mood processes. Their effectiveness in the treatment of psychiatric diseases was known before their prohibition. An increasing number of recent studies, due to the indisputable resurgence of serotonergic hallucinogens, have shown their efficacy in alleviating depression, anxiety, substance abuse therapies, and...